HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
An-Ping Lin Selected Research
An-Ping Lin Research Topics
Disease
6
Neoplasms (Cancer)
01/2018 - 05/2012
3
Lymphoma (Lymphomas)
01/2022 - 03/2016
3
B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 08/2013
3
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 05/2012
1
Hypoxia (Hypoxemia)
01/2022
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018
Drug/Important Bio-Agent (IBA)
4
Type 4 Cyclic Nucleotide Phosphodiesterases
IBA
01/2022 - 03/2016
3
Cyclic AMP (AMP, Cyclic)
IBA
01/2022 - 03/2016
3
Roflumilast
IBA
01/2018 - 03/2016
3
Phosphodiesterase 4 Inhibitors
IBA
01/2018 - 03/2016
2
Phosphotransferases (Kinase)
IBA
01/2018 - 03/2017
2
Enzymes
IBA
03/2016 - 07/2015
1
Oxygen (Dioxygen)
IBA
01/2022
1
Cytokines
IBA
01/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
Transcription Factors (Transcription Factor)
IBA
01/2020
1
Agammaglobulinaemia Tyrosine Kinase
IBA
01/2018
1
idelalisib
IBA
01/2018
1
Prednisone (Sone)
FDA Link
Generic
03/2017
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2016
1
Phosphoric Diester Hydrolases (Phosphodiesterases)
IBA
03/2016
1
Dioxygenases
IBA
07/2015
1
Nucleotides
IBA
08/2013
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
08/2013
1
MicroRNAs (MicroRNA)
IBA
05/2012